US Stock MarketDetailed Quotes

IGMS IGM Biosciences

Watchlist
  • 1.390
  • +0.050+3.73%
Close Mar 11 16:00 ET
  • 1.390
  • 0.0000.00%
Post 16:05 ET
83.09MMarket Cap-0.43P/E (TTM)

IGM Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.41%-153M
27.47%-34.82M
4.33%-38.39M
29.62%-37.37M
16.82%-42.42M
-3,184.32%-192.23M
-26.81%-48.01M
0.72%-40.12M
-147.71%-53.11M
-31.13%-51M
Net income from continuing operations
20.54%-195.8M
39.62%-36.65M
0.90%-61.43M
25.64%-47.9M
16.01%-49.82M
-11.45%-246.42M
-15.44%-60.7M
-6.81%-61.99M
-9.95%-64.42M
-14.29%-59.31M
Depreciation and amortization
10.09%9.11M
7.89%2.35M
2.12%2.31M
4.74%2.28M
30.77%2.18M
36.25%8.28M
14.91%2.18M
49.70%2.26M
50.48%2.17M
35.95%1.66M
Other non cash items
-38.07%9.41M
-54.52%1.77M
-52.05%2.52M
-14.60%2.56M
-15.85%2.55M
26.54%15.19M
-27.37%3.9M
81.83%5.26M
8.73%3M
208.66%3.03M
Change In working capital
-6.16%-7.11M
-961.90%-6.83M
-24.04%3.6M
84.69%-896K
39.60%-2.98M
-104.31%-6.69M
61.57%-643K
42.69%4.74M
-103.79%-5.85M
-471.76%-4.94M
-Change in prepaid assets
-71.95%480K
-31.54%1.12M
-129.50%-1.1M
85.30%-529K
1,801.72%987K
376.60%1.71M
509.75%1.64M
274.82%3.73M
-283.72%-3.6M
-106.22%-58K
-Change in payables and accrued expense
36.88%-2.66M
-478.15%-6.14M
213.06%5.2M
273.53%2.27M
-13.87%-3.98M
-139.30%-4.21M
-567.92%-1.06M
-79.12%1.66M
-134.50%-1.31M
-296.60%-3.5M
-Change in other current assets
286.60%750K
-54.02%80K
114.71%292K
357.89%174K
232.47%204K
120.06%194K
45.00%174K
112.11%136K
442.86%38K
-631.03%-154K
-Change in other current liabilities
-32.67%-3M
-98.92%-1.48M
0.36%-273K
-189.57%-1.56M
143.08%305K
41.34%-2.26M
13.81%-743K
73.78%-274K
46.57%-537K
25.00%-708K
-Change in other working capital
-25.77%-2.68M
36.71%-412K
-1.38%-516K
-179.91%-1.25M
4.79%-497K
-101.43%-2.13M
-75.00%-651K
-53.78%-509K
---448K
---522K
Cash from discontinued investing activities
Operating cash flow
20.41%-153M
27.47%-34.82M
4.33%-38.39M
29.62%-37.37M
16.82%-42.42M
-3,184.32%-192.23M
-26.81%-48.01M
0.72%-40.12M
-147.71%-53.11M
-31.13%-51M
Investing cash flow
Cash flow from continuing investing activities
-6.14%64.16M
222.49%18M
-33.57%12.99M
487.73%24.52M
-87.61%8.65M
130.29%68.36M
21.89%-14.69M
621.58%19.55M
96.56%-6.33M
465.51%69.82M
Net PPE purchase and sale
53.05%-5.81M
40.47%-862K
58.32%-1.29M
69.79%-1.18M
36.91%-2.48M
-21.31%-12.38M
46.27%-1.45M
-13.72%-3.08M
-114.65%-3.91M
-32.25%-3.94M
Net investment purchase and sale
-13.33%69.97M
242.39%18.86M
-36.94%14.27M
1,165.75%25.71M
-84.90%11.14M
137.48%80.74M
17.81%-13.25M
2,282.45%22.63M
98.68%-2.41M
557.40%73.76M
Cash from discontinued investing activities
Investing cash flow
-6.14%64.16M
222.49%18M
-33.57%12.99M
487.73%24.52M
-87.61%8.65M
130.29%68.36M
21.89%-14.69M
621.58%19.55M
96.56%-6.33M
465.51%69.82M
Financing cash flow
Cash flow from continuing financing activities
-97.92%2.39M
4.48%420K
-97.31%1.2M
-99.12%615K
102.67%152K
-47.55%115.07M
-16.60%402K
14,929.97%44.64M
-67.99%69.95M
4.17%75K
Net common stock issuance
--0
--0
--0
----
----
-47.90%113.56M
--0
--44.62M
----
----
Proceeds from stock option exercised by employees
63.56%2.46M
4.48%420K
5,359.09%1.2M
-35.52%648K
154.67%191K
7.81%1.5M
-16.60%402K
-92.59%22K
108.07%1.01M
-43.61%75K
Net other financing activities
---72K
--0
--0
---33K
---39K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-97.92%2.39M
4.48%420K
-97.31%1.2M
-99.12%615K
102.67%152K
-47.55%115.07M
-16.60%402K
14,929.97%44.64M
-67.99%69.95M
4.17%75K
Net cash flow
Beginning cash position
-7.22%113.11M
-75.45%43.07M
-55.56%67.26M
-43.55%79.5M
-7.22%113.11M
-9.04%121.92M
-1.51%175.41M
-31.82%151.34M
85.01%140.82M
-9.04%121.92M
Current changes in cash
-881.49%-86.45M
73.67%-16.4M
-200.54%-24.2M
-216.28%-12.24M
-277.83%-33.61M
27.30%-8.81M
-10.88%-62.3M
154.87%24.07M
-92.79%10.52M
132.63%18.9M
End cash Position
-76.43%26.66M
-76.43%26.66M
-75.45%43.07M
-55.56%67.26M
-43.55%79.5M
-7.22%113.11M
-7.22%113.11M
-1.51%175.41M
-31.82%151.34M
85.01%140.82M
Free cash flow
22.37%-158.85M
27.85%-35.68M
8.16%-39.68M
32.32%-38.59M
18.26%-44.9M
-1,174.13%-204.61M
-21.95%-49.46M
-0.19%-43.2M
-152.08%-57.02M
-31.21%-54.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.41%-153M27.47%-34.82M4.33%-38.39M29.62%-37.37M16.82%-42.42M-3,184.32%-192.23M-26.81%-48.01M0.72%-40.12M-147.71%-53.11M-31.13%-51M
Net income from continuing operations 20.54%-195.8M39.62%-36.65M0.90%-61.43M25.64%-47.9M16.01%-49.82M-11.45%-246.42M-15.44%-60.7M-6.81%-61.99M-9.95%-64.42M-14.29%-59.31M
Depreciation and amortization 10.09%9.11M7.89%2.35M2.12%2.31M4.74%2.28M30.77%2.18M36.25%8.28M14.91%2.18M49.70%2.26M50.48%2.17M35.95%1.66M
Other non cash items -38.07%9.41M-54.52%1.77M-52.05%2.52M-14.60%2.56M-15.85%2.55M26.54%15.19M-27.37%3.9M81.83%5.26M8.73%3M208.66%3.03M
Change In working capital -6.16%-7.11M-961.90%-6.83M-24.04%3.6M84.69%-896K39.60%-2.98M-104.31%-6.69M61.57%-643K42.69%4.74M-103.79%-5.85M-471.76%-4.94M
-Change in prepaid assets -71.95%480K-31.54%1.12M-129.50%-1.1M85.30%-529K1,801.72%987K376.60%1.71M509.75%1.64M274.82%3.73M-283.72%-3.6M-106.22%-58K
-Change in payables and accrued expense 36.88%-2.66M-478.15%-6.14M213.06%5.2M273.53%2.27M-13.87%-3.98M-139.30%-4.21M-567.92%-1.06M-79.12%1.66M-134.50%-1.31M-296.60%-3.5M
-Change in other current assets 286.60%750K-54.02%80K114.71%292K357.89%174K232.47%204K120.06%194K45.00%174K112.11%136K442.86%38K-631.03%-154K
-Change in other current liabilities -32.67%-3M-98.92%-1.48M0.36%-273K-189.57%-1.56M143.08%305K41.34%-2.26M13.81%-743K73.78%-274K46.57%-537K25.00%-708K
-Change in other working capital -25.77%-2.68M36.71%-412K-1.38%-516K-179.91%-1.25M4.79%-497K-101.43%-2.13M-75.00%-651K-53.78%-509K---448K---522K
Cash from discontinued investing activities
Operating cash flow 20.41%-153M27.47%-34.82M4.33%-38.39M29.62%-37.37M16.82%-42.42M-3,184.32%-192.23M-26.81%-48.01M0.72%-40.12M-147.71%-53.11M-31.13%-51M
Investing cash flow
Cash flow from continuing investing activities -6.14%64.16M222.49%18M-33.57%12.99M487.73%24.52M-87.61%8.65M130.29%68.36M21.89%-14.69M621.58%19.55M96.56%-6.33M465.51%69.82M
Net PPE purchase and sale 53.05%-5.81M40.47%-862K58.32%-1.29M69.79%-1.18M36.91%-2.48M-21.31%-12.38M46.27%-1.45M-13.72%-3.08M-114.65%-3.91M-32.25%-3.94M
Net investment purchase and sale -13.33%69.97M242.39%18.86M-36.94%14.27M1,165.75%25.71M-84.90%11.14M137.48%80.74M17.81%-13.25M2,282.45%22.63M98.68%-2.41M557.40%73.76M
Cash from discontinued investing activities
Investing cash flow -6.14%64.16M222.49%18M-33.57%12.99M487.73%24.52M-87.61%8.65M130.29%68.36M21.89%-14.69M621.58%19.55M96.56%-6.33M465.51%69.82M
Financing cash flow
Cash flow from continuing financing activities -97.92%2.39M4.48%420K-97.31%1.2M-99.12%615K102.67%152K-47.55%115.07M-16.60%402K14,929.97%44.64M-67.99%69.95M4.17%75K
Net common stock issuance --0--0--0---------47.90%113.56M--0--44.62M--------
Proceeds from stock option exercised by employees 63.56%2.46M4.48%420K5,359.09%1.2M-35.52%648K154.67%191K7.81%1.5M-16.60%402K-92.59%22K108.07%1.01M-43.61%75K
Net other financing activities ---72K--0--0---33K---39K--------------------
Cash from discontinued financing activities
Financing cash flow -97.92%2.39M4.48%420K-97.31%1.2M-99.12%615K102.67%152K-47.55%115.07M-16.60%402K14,929.97%44.64M-67.99%69.95M4.17%75K
Net cash flow
Beginning cash position -7.22%113.11M-75.45%43.07M-55.56%67.26M-43.55%79.5M-7.22%113.11M-9.04%121.92M-1.51%175.41M-31.82%151.34M85.01%140.82M-9.04%121.92M
Current changes in cash -881.49%-86.45M73.67%-16.4M-200.54%-24.2M-216.28%-12.24M-277.83%-33.61M27.30%-8.81M-10.88%-62.3M154.87%24.07M-92.79%10.52M132.63%18.9M
End cash Position -76.43%26.66M-76.43%26.66M-75.45%43.07M-55.56%67.26M-43.55%79.5M-7.22%113.11M-7.22%113.11M-1.51%175.41M-31.82%151.34M85.01%140.82M
Free cash flow 22.37%-158.85M27.85%-35.68M8.16%-39.68M32.32%-38.59M18.26%-44.9M-1,174.13%-204.61M-21.95%-49.46M-0.19%-43.2M-152.08%-57.02M-31.21%-54.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+8.91%
Coinbase
COIN
+6.95%
Tesla
TSLA
+3.79%
Vale SA
VALE
+1.73%
NVIDIA
NVDA
+1.66%

Unlock the Full List